As of Jan 19
| +0.10 / +1.74%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.38, with a high estimate of 20.00 and a low estimate of 8.00. The median estimate represents a +94.44% increase from the last price of 5.85.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.